1Operating income and net income were both -$31.8K for Q3 FY2026, reflecting zero revenue and continued general and administrative spending as the Company remains in pre-commercial development.
2Diluted EPS was $0.01 for Q3 FY2026 — a nominal positive value derived from GAAP reporting conventions despite an underlying net loss, underscoring the absence of revenue-generating operations.
3Net cash used in operating activities totaled $68,707 for the nine months ended February 28, 2026, aligning with management’s stated focus on scaling infrastructure and preparing for market introduction.
4The Company has no historical financial information upon which to evaluate performance, as confirmed in its Management Discussion and Analysis, reinforcing material uncertainty around future operations.
5Management expects research and development and general and administrative costs to continue increasing as it expands its development team, invests in technology, and prepares the product for market introduction.
6The Company has no off-balance sheet arrangements that are reasonably likely to affect its financial condition, liquidity, or capital resources — a direct affirmation from Item 2 of the filing.